日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

N-glycosylation of PD-L1 modulates the efficacy of immune checkpoint blockades targeting PD-L1 and PD-1

PD-L1的N-糖基化调节靶向PD-L1和PD-1的免疫检查点阻断疗法的疗效。

Bar Kaufman ,Muhammad Abu-Ahmad ,Olga Radinsky ,Eman Gharra ,Tal Manko ,Baisali Bhattacharya ,Daniela Gologan ,Nofar Erlichman ,Tsipi Meshel ,Yoav Nuta ,Tomer Cooks ,Moshe Elkabets ,Adit Ben-Baruch ,Angel Porgador

The Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Breast Cancer Are Regulated by N-Linked Glycosylation-Dependent Activation of STAT3 and STAT1

PD-L1在乳腺癌中的细胞自主促转移活性受STAT3和STAT1的N-连接糖基化依赖性激活调控。

Nofar Erlichman ,Tsipi Meshel ,Tamir Baram ,Alaa Abu Raiya ,Tamar Horvitz ,Hagar Ben-Yaakov ,Adit Ben-Baruch

Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042

更正:Erlichman 等人。人类乳腺癌中 PD-L1 的肿瘤细胞自主促转移活性由 PD-L1-S283 和趋化因子轴介导。癌症 2022, 14, 1042

Nofar Erlichman, Tamir Baram, Tsipi Meshel, Dina Morein, Benny Da'adoosh, Adit Ben-Baruch

Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes

人类乳腺癌中 PD-L1 的肿瘤细胞自主促转移活性由 PD-L1-S283 和趋化因子轴介导

Nofar Erlichman, Tamir Baram, Tsipi Meshel, Dina Morein, Benny Da'adoosh, Adit Ben-Baruch

Inflammation-Driven Regulation of PD-L1 and PD-L2, and Their Cross-Interactions with Protective Soluble TNFα Receptors in Human Triple-Negative Breast Cancer

PD-L1 和 PD-L2 的炎症驱动调节及其与人类三阴性乳腺癌中保护性可溶性 TNFα 受体的交叉相互作用

Tamir Baram, Nino Oren, Nofar Erlichman, Tsipi Meshel, Adit Ben-Baruch

Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors

化疗使三阴性乳腺癌中CD8+ TNFR2+ TILs的比例增加

Tamir Baram ,Nofar Erlichman ,Maya Dadiani ,Nora Balint-Lahat ,Anya Pavlovski ,Tsipi Meshel ,Dana Morzaev-Sulzbach ,Einav Nili Gal-Yam ,Iris Barshack ,Adit Ben-Baruch